-
1 Comment
Landec Corporation is currently in a long term uptrend where the price is trading 2.2% above its 200 day moving average.
From a valuation standpoint, the stock is 96.1% cheaper than other stocks from the Other sector with a price to sales ratio of 0.5.
Landec Corporation's total revenue sank by 8.2% to $131M since the same quarter in the previous year.
Its net income has dropped by 97.3% to $-13M since the same quarter in the previous year.
Finally, its free cash flow grew by 91.3% to $-1M since the same quarter in the previous year.
Based on the above factors, Landec Corporation gets an overall score of 3/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | US5147661046 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 208M |
|---|---|
| PE Ratio | None |
| Target Price | 14.4 |
| Beta | 0.8 |
| Dividend Yield | None |
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LDE.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
